GlaxoSmithkline Consumer Healthcare lost 0.32% to Rs 4,858 at 10:20 IST on BSE after net profit rose 8.46% to Rs 130.12 crore on 8.92% growth in total income to Rs 1011.73 crore in Q1 June 2014 over Q1 June 2013.
The Q1 result was announced after market hours on Wednesday, 6 August 2014.
Meanwhile, the S&P BSE Sensex was up 27.94 points or 0.11% at 25,693.21.
On BSE, so far 7,624 shares were traded in the counter as against average daily volume of 319 shares in the past two weeks.
The stock was volatile. The stock lost 0.32% at the day's high of Rs 4,858 so far during the day. The stock lost as much as 2.37% at the day's low of Rs 4,757.75 so far during the day.
GlaxoSmithkline Consumer Healthcare (GSK Consumer Healthcare) is a leading player in the malted food drinks segment. Its major brands include Horlicks, Boost, Viva and Maltova.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app